Home › Therapeutic areas › Neurology › Multiple System Atrophy
Multiple System Atrophy (4 companies)
Companies with an active program in Multiple System Atrophy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ACIU | AC Immune | Neurology Rare | 1 | Phase 3 | $222M | 11 |
| ATHE | Alterity Therapeutics | Neurology Rare | 1 | Phase 2 | $46.4M | 2 |
| PMN | ProMIS Neurosciences | Neurology Rare | 1 | Phase 1 | $37.3M | 6 |
| TLSA | Tiziana Life Sciences | ImmunologyNeurology Rare | 1 | Phase 2 | $87.8M | 5 |
No companies match.